Singular Genomics Systems, Inc. (OMIC)
NASDAQ: OMIC · Real-Time Price · USD
22.59
+0.28 (1.23%)
Nov 5, 2024, 1:07 PM EST - Market open

Singular Genomics Systems Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Net Income
-91.89-94.82-90.88-98.77-27.95-12.32
Depreciation & Amortization
7.037.226.031.130.640.35
Other Amortization
0.160.150.170.280.23-
Loss (Gain) From Sale of Assets
--0.060.09--
Asset Writedown & Restructuring Costs
-1.9----
Loss (Gain) From Sale of Investments
-3.17-1.120.681.870.08-0.01
Stock-Based Compensation
10.5611.413.679.231.060.17
Other Operating Activities
3.863.86-37.380.2-
Change in Accounts Receivable
-0.410.35-0.91---
Change in Inventory
-5.6-3.54-13.49---
Change in Accounts Payable
1.610.27-1.171.85-0.150.24
Change in Other Net Operating Assets
0.390.68-1.25-4.771.010.17
Operating Cash Flow
-77.46-73.65-87.09-51.7-24.87-11.4
Capital Expenditures
-0.53-0.97-6.02-4.86-1.38-0.8
Investment in Securities
32.0214.78-33.54-12625.39-30.7
Investing Cash Flow
31.4913.81-39.57-130.8624.01-31.5
Long-Term Debt Issued
---1417.52.46
Long-Term Debt Repaid
----10.4--
Net Debt Issued (Repaid)
---130.67.52.46
Issuance of Common Stock
0.160.721.35241.570.050.04
Repurchase of Common Stock
-0.01-0.02-0.45-0.04--
Other Financing Activities
-----0.03-0.2
Financing Cash Flow
0.150.70.9372.137.5247.3
Net Cash Flow
-45.81-59.14-125.76189.576.654.41
Free Cash Flow
-77.98-74.62-93.12-56.57-26.25-12.2
Free Cash Flow Margin
-2863.90%-2563.28%-12172.03%---
Free Cash Flow Per Share
-31.71-30.75-39.26-36.09-74.47-42.46
Cash Interest Paid
0.910.940.560.570.460.01
Levered Free Cash Flow
-41.85-36.81-59.47-36.23-15.81-
Unlevered Free Cash Flow
-41.3-36.27-59.16-35.98-15.6-
Change in Net Working Capital
-2.81-9.1414.413.18-1.29-
Source: S&P Capital IQ. Standard template. Financial Sources.